Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole vs Fluconazole for Oropharyngeal Candidiasis in HIV-Positive Patients
NCT00002399Phase 2Completed
- Sponsor
- Merck & Co.
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of posaconazole in oropharyngeal candidiasis (OPC), sponsored by Merck & Co.. Status: completed.
02
Drugs
posaconazole
03
Conditions
oropharyngeal candidiasis (OPC)
Beyond the preview
Go deeper on NCT00002399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002399.